Figure 2.

Cutaneous lips without any hyperkeratotic scale, perioral lesions, or scaring, photo was taken 3 months after starting dupilumab.

Cutaneous lips without any hyperkeratotic scale, perioral lesions, or scaring, photo was taken 3 months after starting dupilumab.